Novo Nordisk submitted an NDA (new drug application) to the FDA on December 18, 2025, which is the formal step companies take when seeking approval for a medication to be marketed for public use
When both are supported together, the body may be better positioned to maintain the metabolic function and DNA health that underlie long-term wellbeing
GSH activity is facilitated by activation of the Kelch-like ECH-associated protein 1 (Keap1)-Nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) redox regulator pathway, releasing Nrf2 that regulates expression of genes controlling antioxidant, inflammatory and immune system responses
Note: Dosage figures from peptide-therapy contexts are based on practitioner protocols, not regulatory-approved guidelines
[30] At the injection site, its possible to have some redness, swelling, or irritation
Is Skin Bright - Glutathione Complex tested on animals